KVKarin Voordeckers

Karin Voordeckers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karin Voordeckers has a total of 196 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin J. Verstrepen

    KU Leuven, Department of Microbial and Molecular Systems (M²S) , Centre of Microbial and Plant Genetics (CMPG), B-3000 Leuven

    31 shared publications
  • Elisa van der Zande

    Laboratory of Systems Biology, VIB-KU Leuven Center for Microbiology, Leuven, Belgium

    6 shared publications
  • Jan Steensels

    VIB - KU Leuven Center for Microbiology, Gaston Geenslaan 1, B-3001 Leuven, Belgium; CMPG Laboratory of Genetics and Genomics, Department M2S, KU Leuven, Gaston Geenslaan 1, B-3001 Leuven, Belgium; Leuven Institute for Beer Research (LIBR), Gaston Geenslaan 1, B-3001 Leuven, Belgium

    5 shared publications
  • Bo Zhu

    VIB Laboratory for Systems Biology, Leuven, Belgium

    4 shared publications
  • Kathleen Marchal

    Department of Plant Biotechnology and Bioinformatics, Ghent University , Ghent 9052

    4 shared publications
  • Brigida Gallone

    VIB - KU Leuven Center for Microbiology, Gaston Geenslaan 1, B-3001 Leuven, Belgium; CMPG Laboratory of Genetics and Genomics, Department M2S, KU Leuven, Gaston Geenslaan 1, B-3001 Leuven, Belgium; Leuven Institute for Beer Research (LIBR), Gaston Geenslaan 1, B-3001 Leuven, Belgium

    3 shared publications

Latest Publications

  • Open Access

    Harnessing yeast biodiversity to identify superior chassis strains for metabolic engineering and precision fermentation

    by Yanmei Zhu, Karin Voordeckers, Jan Steensels, Kevin J Verstrepen

    Microbial cell factories are increasingly used for the sustainable production of fuels, chemicals and pharmaceuticals. Yeasts are particularly suitable as production hosts because of their metabolic flexibility, robustness, and expanding synthetic biology toolkits. Metabolic engineering of yeast historically relied on a narrow set of reference species and strains, especially Saccharomyces cerevisiae. Recent studies, however, show that applying identical pathway designs to different strain backgrounds or species can yield significant differences in titer, rate and yield (TRY). In this review, we examine how diversity within and between species in genomic features, metabolic regulation, substrate utilization and stress tolerance shapes chassis performance. We focus on eight species, including S. cerevisiae, Yarrowia lipolytica, Kluyveromyces marxianus, Komagataella phaffii, Ogataea polymorpha, Rhodotorula toruloides, Lipomyces starkeyi and Pichia kudriavzevii. We highlight that different species and strain backgrounds provide distinct advantages depending on the target product, pathway requirements, substrate, and process conditions. Finally, we discuss the transition from empirical strain screening toward diversity-informed and predictive chassis selection through multi-omics, phenotyping, metabolic modeling, and machine learning. We propose that chassis identity should be treated as a design variable, and that chassis selection should become an integral part of the Design–Build–Test–Learn cycle to develop optimal cell factories.

  • Evolutionary tuning of the molecular charge state of UBP24 shapes responses to high temperature

    by Shao-Li Yang, Hongyan Liu, Xiangyu Xu, Anton Gorkovskiy, Monica L. Garcia Gomez, Kirsten Ten Tusscher, Jennifer Molinet, Božena Klodová, Tingting Zhu, Cassio Flavio Fonseca De Lima, et al.

  • Open Access

    Intron location and sequence modulate gene expression in Yarrowia lipolytica

    by Qi Qi, Pedro Tomaz da Silva, Vasileios Vangalis, Seppe Dockx, Jan Steensels, Karin Voordeckers, Julien Gagneur, Kevin J Verstrepen

    Introns are widespread among eukaryotic genomes. While intron-containing genes often show higher expression than genes lacking introns, the intron features influencing gene expression remain largely elusive. Here, we systematically characterize the intron landscape of Yarrowia lipolytica, an oleaginous yeast that is increasingly used as a microbial cell factory. Transcriptome analysis across 12 environments identified 2421 introns in 1430 genes, including 1302 newly discovered introns and 479 newly annotated intron-containing genes. We find that intron-containing genes exhibit higher and more stable expression across conditions and identify six key intron features, including the 5′ splice motif, 3′ splice motif, branch point motif, distance from branch point to 3′ splice site, GC content, and intron size, that influence splicing efficiency and gene expression. A linear regression model based on these features robustly captures the intron’s effect on gene expression, enabling us to select and test 55 different introns that modulate expression of a reporter gene by 200-fold. Moreover, we demonstrate that intron effects are robust across genomic contexts and identify a previously uncharacterized intron, I3, that strongly enhances gene expression and protein production. Together, our results provide new fundamental insights and open new avenues for using introns as regulatory elements.


  • Open Access

    Gim3 buffers and potentiates de novo mutations that affect fluconazole susceptibility in yeast

    by Mohammed T Tawfeeq, Dimitrios Konstantinidis, Ana Lucia Rocha Iraizos, Wouter Van Genechten, Jolien Vreys, Lieselotte Vermeersch, Karin Voordeckers, Patrick Van Dijck, Kevin J Verstrepen

    Gim3 is an evolutionarily conserved component of the prefoldin chaperone complex, involved in protein folding. We previously found that GIM3 genetically interacts with many de novo mutations in Saccharomyces cerevisiae . Removing GIM3 from mutagenized S. cerevisiae cells significantly affected the fitness effect of mutations. This indicates that Gim3 might change the evolutionary impact of de novo mutations by either buffering (hiding) or potentiating (increasing) their phenotypic effects, depending on the environmental or genetic context. Here, we investigated Gim3’s role in shaping the evolutionary fate of de novo mutations under fluconazole stress, an antifungal drug used to combat fungal infections. Applying both strong and moderate fluconazole stress in the presence or absence of GIM3 revealed that Gim3 potentiates fluconazole susceptibility (resistance and tolerance) by enabling mutations to have immediate phenotypic effects. Deleting GIM3 reduced growth in fluconazole in most mutants, indicating that GIM3 could be a promising target for new antifungal therapies against drug-resistant infections. Importantly, Gim3 also modulates fluconazole susceptibility of the fungal pathogen Nakaseomyces glabratus , further highlighting Gim3’s role in fluconazole resistance and tolerance.


  • Open Access

    Evolutionary tuning of molecular charge state of UBP24 shapes eukaryotic responses to high temperature

    by Ive De Smet, Shao-Li Yang, Xiangyu Xu, Hongyan Liu, Anton Gorkovskiy, Tingting Zhu, Cássio Flávio Fonseca de Lima, Brigitte Van De Cotte, Jennifer Molinet, Karin Voordeckers, et al.

    Protein evolution is shaped by sequence variation that modulates protein properties, e.g., through gain or loss of post-translational modifications. Among these, reversible phosphorylation alters a protein’s overall electrical charge and enables organisms to dynamically respond to environmental fluctuations. In plants, the hydro-active opening of stomata, microscopic pores that regulate gas exchange and leaf temperature, is governed by phosphorylation-dependent signalling. Here, we identify a mechanism involving the deubiquitylase UBIQUITIN-SPECIFIC PROTEASE 24 (UBP24) that promotes stomatal opening in Arabidopsis thaliana under heat. UBP24 is phosphorylated at serine 360 by the kinase OPEN STOMATA 1 (OST1), which is activated by B4 RAF kinases in response to heat stress. This phosphorylation stabilizes UBP24, enabling deubiquitylation of a plasma membrane H⁺-ATPase to promote stomatal opening. This reveals a novel heat-responsive signalling pathway that evolved in vascular plants to regulate stomatal function. Strikingly, a similar evolutionary feature exists in Saccharomyces cerevisiae, where the UBP24 homolog Ubp3 requires a constitutively negatively charged residue at the homologous site to support growth after heat shock. Our findings uncover a conserved molecular mechanism in which negative charge, via phosphorylation or acidic residues, modulates deubiquitylase function, supporting adaptive thermal responses across eukaryotes and highlighting how charge-based regulation promotes cellular resilience under stress.


  • Open Access

    Genes involved in protein folding and chromatin organization buffer genetic variation

    by Jens Frickel, Mohammed Talib Tawfeeq, Emily Baker, Sara Baco, Jonas Rombout, Karin Voordeckers, Daniel F. Jarosz, Sibylle C. Vonesch, Kevin Joan Verstrepen

    SUMMARY: Mutations are not always phenotypically active or show different effects in different individuals. While the mechanisms underlying this variable relationship between mutations and phenotypes are largely elusive, some specific genes may influence the phenotypic effects of cryptic variation. We employ the toolbox of Saccharomyces cerevisiae to perform a genome-wide screen aimed at identifying these so-called genetic buffer genes. Measuring the fitness of 1.8 million mutated strains identified a small set of evolutionary conserved buffer genes involved in protein folding and chromatin organization, including GIM3, SSA2, HOG1 and FKH2 . Deletion of these genes increases the fitness effect of de novo mutations as well as standing genetic variation, with some mutations becoming adaptive. Moreover, losing a buffer gene results in a decline of standing genetic variation. Together, these results reveal a set of conserved genes that influence the phenotypic outcome of mutations and play a role in complex genetics and incomplete penetrance.


  • Open Access

    Mutational robustness and the role of buffer genes in evolvability

    by Mohammed T Tawfeeq, Karin Voordeckers, Pieter van Den Berg, Sander K Govers, Jan Michiels, Kevin J Verstrepen

    Organisms rely on mutations to fuel adaptive evolution. However, many mutations impose a negative effect on fitness. Cells may have therefore evolved mechanisms that affect the phenotypic effects of mutations, thus conferring mutational robustness. Specifically, so-called buffer genes are hypothesized to interact directly or indirectly with genetic variation and reduce its effect on fitness. Environmental or genetic perturbations can change the interaction between buffer genes and genetic variation, thereby unmasking the genetic variation’s phenotypic effects and thus providing a source of variation for natural selection to act on. This review provides an overview of our understanding of mutational robustness and buffer genes, with the chaperone gene HSP90 as a key example. It discusses whether buffer genes merely affect standing variation or also interact with de novo mutations, how mutational robustness could influence evolution, and whether mutational robustness might be an evolved trait or rather a mere side-effect of complex genetic interactions.


  • Rational evolution for altering the ligand preference of estrogen receptor alpha

    by Roy Eerlings, Purvi Gupta, Xiao Yin Lee, Tien Nguyen, Sarah El Kharraz, Florian Handle, Elien Smeets, Lisa Moris, Wout Devlies, Bram Vandewinkel, et al.

    Estrogen receptor α is commonly used in synthetic biology to control the activity of genome editing tools. The activating ligands, estrogens, however, interfere with various cellular processes, thereby limiting the applicability of this receptor. Altering its ligand preference to chemicals of choice solves this hurdle but requires adaptation of unspecified ligand‐interacting residues. Here, we provide a solution by combining rational protein design with multi‐site‐directed mutagenesis and directed evolution of stably integrated variants in Saccharomyces cerevisiae. This method yielded an estrogen receptor variant, named TERRA, that lost its estrogen responsiveness and became activated by tamoxifen, an anti‐estrogenic drug used for breast cancer treatment. This tamoxifen preference of TERRA was maintained in mammalian cells and mice, even when fused to Cre recombinase, expanding the mammalian synthetic biology toolbox. Not only is our platform transferable to engineer ligand preference of any steroid receptor, it can also profile drug‐resistance landscapes for steroid receptor‐targeted therapies.


  • Open Access

    Mutagenesis techniques for evolutionary engineering of microbes – exploiting CRISPR-Cas, oligonucleotides, recombinases, and polymerases

    by Anna Zimmermann, Julian E. Prieto-Vivas, Karin Voordeckers, Changhao Bi, Kevin J. Verstrepen


  • Open Access

    Ethanol induces replication fork stalling and membrane stress in immortalized laryngeal cells

    by Lore Hoes, Karin Voordeckers, Rüveyda Dok, Bram Boeckx, Bart Steemans, Diyavarshini Gopaul, Philippe Pasero, Sander K. Govers, Diether Lambrechts, Sandra Nuyts, et al.